Cargando…
Lobular breast cancer - the most common special subtype or a most special common subtype?
Lobular breast cancer is not only the second most common breast cancer subtype, known for decades, but also a tumour entity that still poses many unresolved questions. These include questions about the targets and cooperation partners of E-cadherin, the best model systems for translational research,...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531830/ https://www.ncbi.nlm.nih.gov/pubmed/26215581 http://dx.doi.org/10.1186/s13058-015-0606-z |
_version_ | 1782385124469374976 |
---|---|
author | Lehmann, Ulrich |
author_facet | Lehmann, Ulrich |
author_sort | Lehmann, Ulrich |
collection | PubMed |
description | Lobular breast cancer is not only the second most common breast cancer subtype, known for decades, but also a tumour entity that still poses many unresolved questions. These include questions about the targets and cooperation partners of E-cadherin, the best model systems for translational research, and the best tools for detection, surveillance and therapy. Leading experts review the molecular and cellular bases, the model systems, the histopathology and profiling approaches, risk factors, imaging tools and therapeutic options for lobular breast cancer. |
format | Online Article Text |
id | pubmed-4531830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45318302015-08-12 Lobular breast cancer - the most common special subtype or a most special common subtype? Lehmann, Ulrich Breast Cancer Res Editorial Lobular breast cancer is not only the second most common breast cancer subtype, known for decades, but also a tumour entity that still poses many unresolved questions. These include questions about the targets and cooperation partners of E-cadherin, the best model systems for translational research, and the best tools for detection, surveillance and therapy. Leading experts review the molecular and cellular bases, the model systems, the histopathology and profiling approaches, risk factors, imaging tools and therapeutic options for lobular breast cancer. BioMed Central 2015-07-28 2015 /pmc/articles/PMC4531830/ /pubmed/26215581 http://dx.doi.org/10.1186/s13058-015-0606-z Text en © Lehmann. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Editorial Lehmann, Ulrich Lobular breast cancer - the most common special subtype or a most special common subtype? |
title | Lobular breast cancer - the most common special subtype or a most special common subtype? |
title_full | Lobular breast cancer - the most common special subtype or a most special common subtype? |
title_fullStr | Lobular breast cancer - the most common special subtype or a most special common subtype? |
title_full_unstemmed | Lobular breast cancer - the most common special subtype or a most special common subtype? |
title_short | Lobular breast cancer - the most common special subtype or a most special common subtype? |
title_sort | lobular breast cancer - the most common special subtype or a most special common subtype? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531830/ https://www.ncbi.nlm.nih.gov/pubmed/26215581 http://dx.doi.org/10.1186/s13058-015-0606-z |
work_keys_str_mv | AT lehmannulrich lobularbreastcancerthemostcommonspecialsubtypeoramostspecialcommonsubtype |